These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24453245)

  • 1. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
    Ding Y; Wilkinson A; Idris A; Fancke B; O'Keeffe M; Khalil D; Ju X; Lahoud MH; Caminschi I; Shortman K; Rodwell R; Vuckovic S; Radford KJ
    J Immunol; 2014 Feb; 192(4):1982-9. PubMed ID: 24453245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human CD141
    Pearson FE; Chang K; Minoda Y; Rojas IML; Haigh OL; Daraj G; Tullett KM; Radford KJ
    Immunol Cell Biol; 2018 Apr; 96(4):390-400. PubMed ID: 29344995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
    Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
    J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice.
    Meixlsperger S; Leung CS; Rämer PC; Pack M; Vanoaica LD; Breton G; Pascolo S; Salazar AM; Dzionek A; Schmitz J; Steinman RM; Münz C
    Blood; 2013 Jun; 121(25):5034-44. PubMed ID: 23482932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.
    Nizzoli G; Krietsch J; Weick A; Steinfelder S; Facciotti F; Gruarin P; Bianco A; Steckel B; Moro M; Crosti M; Romagnani C; Stölzel K; Torretta S; Pignataro L; Scheibenbogen C; Neddermann P; De Francesco R; Abrignani S; Geginat J
    Blood; 2013 Aug; 122(6):932-42. PubMed ID: 23794066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD141
    Minoda Y; Virshup I; Leal Rojas I; Haigh O; Wong Y; Miles JJ; Wells CA; Radford KJ
    Front Immunol; 2017; 8():1419. PubMed ID: 29163495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
    Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
    J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.
    Canavan M; Walsh AM; Bhargava V; Wade SM; McGarry T; Marzaioli V; Moran B; Biniecka M; Convery H; Wade S; Orr C; Mullan R; Fletcher JM; Nagpal S; Veale DJ; Fearon U
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3
    Iwabuchi R; Ikeno S; Kobayashi-Ishihara M; Takeyama H; Ato M; Tsunetsugu-Yokota Y; Terahara K
    Front Immunol; 2018; 9():1042. PubMed ID: 29892279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β.
    Yu CI; Becker C; Wang Y; Marches F; Helft J; Leboeuf M; Anguiano E; Pourpe S; Goller K; Pascual V; Banchereau J; Merad M; Palucka K
    Immunity; 2013 Apr; 38(4):818-30. PubMed ID: 23562160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
    Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
    Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.
    Maraskovsky E; Brasel K; Teepe M; Roux ER; Lyman SD; Shortman K; McKenna HJ
    J Exp Med; 1996 Nov; 184(5):1953-62. PubMed ID: 8920882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets.
    Chiang MC; Tullett KM; Lee YS; Idris A; Ding Y; McDonald KJ; Kassianos A; Leal Rojas IM; Jeet V; Lahoud MH; Radford KJ
    Eur J Immunol; 2016 Feb; 46(2):329-39. PubMed ID: 26542182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.
    Bachem A; Güttler S; Hartung E; Ebstein F; Schaefer M; Tannert A; Salama A; Movassaghi K; Opitz C; Mages HW; Henn V; Kloetzel PM; Gurka S; Kroczek RA
    J Exp Med; 2010 Jun; 207(6):1273-81. PubMed ID: 20479115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
    Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
    Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
    EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.
    Sittig SP; Bakdash G; Weiden J; Sköld AE; Tel J; Figdor CG; de Vries IJ; Schreibelt G
    Mediators Inflamm; 2016; 2016():3605643. PubMed ID: 27057096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
    Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.